Endothelial dysfunction: Causes and consequences in patients with diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 82, Issue SUPPL. 2, 2008, Pages

  Avogaro, Angelo ^a   Kreutzenberg, Saula Vigili de ^a   Fadini, GianPaolo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Diabetes; Endothelium; Endothelium progenitor cells; Oxidative stress

Indexed keywords

ADIPOCYTOKINE; NITRIC OXIDE;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CELL FUNCTION; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; VASCULAR ENDOTHELIUM;

ADIPOKINES; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 56949103019     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.021     Document Type: Article

References (53)

1. Moncada S., Radomski M.W., and Palmer R.M. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37 (1988) 2495-2501
2. Marletta M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268 (1993) 12231-12234
3. Sporbert A., Mertsch K., Smolenski A., et al. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes. Brain Res. Mol. Brain Res. 67 (1999) 258-266
4. Stump C.S., Clark S.E., and Sowers J.R. Oxidative stress in insulin-resistant conditions: cardiovascular implications. Treat. Endocrinol. 4 (2005) 343-351
5. Delbosc S., Paizanis E., Magous R., et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179 (2005) 43-49
6. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
7. Avogaro A., Pagnin E., and Calo L. Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J. Clin. Endocrinol. Metab. 88 (2003) 1753-1759
8. Papaharalambus C.A., and Griendling K.K. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc. Med. 17 (2007) 48-54
9. Devangelio E., Santilli F., Formoso G., et al. Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic. Biol. Med. 43 (2007) 511-518
10. Naruse K., Rask-Madsen C., Takahara N., et al. Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 55 (2006) 691-698
11. Feener E.P., and King G.L. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail. Monit. 1 (2001) 74-82
12. Koh K.K., Han S.H., and Quon M.J. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J. Am. Coll. Cardiol. 46 (2005) 1978-1985
13. Vladimirova O., Lu F.M., Shawver L., and Kalman B. The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls. Inflamm. Res. 48 (1999) 412-416
14. Zimmet P., Boyko E.J., Collier G.R., and de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann. N. Y. Acad. Sci. 892 (1999) 25-44
15. Abdella N.A., Mojiminiyi O.A., Moussa M.A., et al. Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet. Med. 22 (2005) 278-285
16. Koenig W., Khuseyinova N., Baumert J., Meisinger C., and Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J. Am. Coll. Cardiol. 48 (2006) 1369-1377
17. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
18. Aldhahi W., and Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr. Diab. Rep. 3 (2003) 293-298
19. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur. Cytokine Netw. 13 (2002) 389-391
20. Irace C., Ceravolo R., Notarangelo L., et al. Comparison of endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound. Atherosclerosis 158 (2001) 53-59
21. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39 (2002) 257-265
22. Alam T.A., Seifalian A.M., and Baker D. A review of methods currently used for assessment of in vivo endothelial function. Eur. J. Vasc. Endovasc. Surg. 29 (2005) 269-276
23. Cohn J.N. New approaches to screening for vascular and cardiac risk. Am. J. Hypertens. 14 6 Pt 2 (2001) 218S-220S
24. Weyer C., Yudkin J.S., Stehouwer C.D., Schalkwijk C.G., Pratley R.E., and Tataranni P.A. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 161 (2002) 233-242
25. Meigs J.B., O'Donnell C.J., Tofler G.H., et al. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 55 (2006) 530-537
26. Zhu W., Zhong C., Yu Y., and Li K. Acute effects of hyperglycaemia with and without exercise on endothelial function in healthy young men. Eur. J. Appl. Physiol. 99 (2007) 585-591
27. Title L.M., Cummings P.M., Giddens K., and Nassar B.A. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J. Am. Coll. Cardiol. 36 (2000) 2185-2191
28. Rask-Madsen C., and King G.L. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 46-56
29. Avogaro A., Piarulli F., Valerio A., et al. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 46 (1997) 1040-1046
30. Avogaro A., Toffolo G., Kiwanuka E., de Kreutzenberg S.V., Tessari P., and Cobelli C. L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes 52 (2003) 795-802
31. Khaidar A., Marx M., Lubec B., and Lubec G. L-arginine reduces heart collagen accumulation in the diabetic db/db mouse. Circulation 90 (1994) 479-483
32. Pitkanen O.P., Nuutila P., Raitakari O.T., et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47 (1998) 248-254
33. Villanueva F.S., Glasheen W.P., Sklenar J., and Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage. Circulation 88 (1993) 2596-2606
34. Villanueva F.S., Glasheen W.P., Sklenar J., and Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation 88 (1993) 596-604
35. Scognamiglio R., Negut C., De Kreutzenberg S.V., Tiengo A., and Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 112 (2005) 179-184
36. Scognamiglio R., Negut C., de Kreutzenberg S.V., Tiengo A., and Avogaro A. Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care 29 (2006) 95-100
37. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science (New York, NY) 275 5302 (1997) 964-967
38. Boos C.J., Lip G.Y., and Blann A.D. Circulating endothelial cells in cardiovascular disease. J. Am. Coll. Cardiol. 48 (2006) 1538-1547
39. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001) E1-E7
40. Lambiase P.D., Edwards R.J., Anthopoulos P., et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 109 (2004) 2986-2992
41. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
42. Loomans C.J., de Koning E.J., Staal F.J., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 (2004) 195-199
43. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 45 (2005) 1449-1457
44. Fadini G.P., Sartore S., Albiero M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2140-2146
45. Mather K.J., Verma S., and Anderson T.J. Improved endothelial function with metformin in type 2 diabetes mellitus. J. Am. Coll. Cardiol. 37 (2001) 1344-1350
46. Ueba H., Kuroki M., Hashimoto S., et al. Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway. Atherosclerosis 183 (2005) 35-39
47. Schiekofer S., Rudofsky Jr. G., Andrassy M., et al. Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B. Diabetes Obes. Metab. 5 (2003) 251-261
48. Gallo A., Ceolotto G., Pinton P., et al. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes 54 (2005) 1123-1131
49. Ceolotto G., Gallo A., Papparella I., et al. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2627-2633
50. Vinik A., Parson H., and Ullal J. The role of PPARs in the microvascular dysfunction in diabetes. Vascul. Pharmacol. 45 (2006) 54-64
51. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356 (2007) 2457-2471
52. Son N.H., Park T.S., Yamashita H., et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J. Clin. Invest. 117 (2007) 2791-2801
53. Yki-Jarvinen H. Insulin resistance and endothelial dysfunction. Best Pract. Res. Clin. Endocrinol. Metab. 17 (2003) 411-430